Triple-negative breast cancer (TNBC) is one of most aggressive forms of breast cancer. It is characterized by a lack of hormonal receptors (estrogen and progesterone) and of overexpression of Human epidermal Growth factor 2 receptor. This study presents TNBC data from the Geneva Cancer Registry in terms of occurrence, tumor characteristics, treatment and survival.